Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
March 07 2024 - 7:59AM
Business Wire
In collaboration with The Blue Hat Foundation,
“Box Out Colon Cancer” offers a timely spotlight on screening and
prevention for the nation’s #2 cancer-related killer1
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of
cancer screening and diagnostic tests, is teaming up with iconic
pro basketball all-star and Kentucky legend Jamal Mashburn to
introduce "Box Out Colon Cancer," in observance of Colorectal
Cancer Awareness Month and the most exciting time in college
basketball. This national educational campaign will encourage
everyone 45 and older to screen for colon cancer – a disease
affecting people of all races, genders, and ethnicities – in line
with American Cancer Society recommendations.2
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240307418330/en/
Basketball great Jamal Mashburn is
spreading the word about the importance of colorectal cancer
screening beginning at age 45 with the "Box Out Colon Cancer"
campaign. (Photo: Business Wire)
“Box Out Colon Cancer” is a direct response to the alarming,
increasing rates of colon cancer diagnoses and deaths under the age
of 50.3 With support from Mashburn, “Box Out Colon Cancer” is
issuing a challenge to some of the nation’s leading college
basketball coaches – over the age of 45 – asking them to get
screened for colon cancer and encouraging others to do the
same.
“Both with basketball and colon cancer, the best defense is a
good offense,” says Mashburn, who took up the cause in loving
memory of his mother, Helen, who battled colon cancer in her
lifetime. “I’m encouraging others to speak with their doctors about
what’s right for them and ‘Box Out Colon Cancer.’ Taking preventive
measures on your health isn’t just for you – it’s also for your
loved ones and the years you deserve with them.”
Colon cancer screenings can play a critical role by catching the
disease early when it is more treatable and stopping the cancer
before it can grow and spread. When caught in early stages, colon
cancer is treatable in about 90% of people.4,A For more resources
and information on available screening options, visit
BoxOutColonCancer.com.
This national campaign was created in collaboration with The
Blue Hat Foundation, a grassroots colon cancer non-profit
organization committed to promoting colon cancer screening through
their "Screening Madness" campaign designed to target young adults,
African American men, and other at-risk communities by using
compelling sports visuals and informative health education. While
all those age 45 and older could benefit from colon cancer
screenings, the need is particularly critical for the African
American population as they are 20% more likely to develop and 40%
more likely to die from colon cancer than most other groups.5
“We are honored to join Exact Sciences in putting a ‘full court
press’ on breaking colon cancer screening stigmas, particularly in
the Black community,” says Candace Henley, founder of The Blue Hat
Foundation. “Together, we can ‘Box Out Colon Cancer,’ one screening
at a time.”
“At Exact Sciences, we work hard to drive awareness of the
importance of timely colorectal cancer screening and to provide an
accurate and easy-to-use option for people to screen from home,”
says Paul Limburg, Exact Sciences chief medical officer, Screening.
“We are thrilled Jamal Mashburn and The Blue Hat Foundation share
the same passion for getting people screened, and our hope is to
inspire and motivate people ages 45 and up to take action and get
screened.”
If you are 45 or older, talk to your doctor about the right
screening option for you to Box Out Colon Cancer. For more
information and resources, and to challenge someone you know 45+ to
get screened, visit BoxOutColonCancer.com.
__________________
A
Based on 5-year survival.
About Exact Sciences Corp. A leading provider of cancer
screening and diagnostic tests, Exact Sciences gives patients and
health care professionals the clarity needed to take life-changing
action earlier. Building on the success of the Cologuard® and
Oncotype® tests, Exact Sciences is investing in its pipeline to
develop innovative solutions for use before, during, and after a
cancer diagnosis. For more information, visit ExactSciences.com,
follow Exact Sciences on X (formerly known as Twitter)
@ExactSciences, or find Exact Sciences on LinkedIn and
Facebook.
About The Blue Hat Foundation The Blue Hat Foundation was
founded in 2015 by colorectal cancer survivor Candace Henley. Its
mission is to educate, raise awareness and provide resources to
free screenings for minority and medically underserved communities.
It accomplishes this goal via grassroots efforts like “Blue Hat
Bowtie Sunday” to share the importance of CRC screening in church
communities and its “Screening Madness” effort in partnership with
the Big 10 Cancer Research Consortium. For more information visit
thebluehatfoundation.org or find them on Facebook.
References
- World Health Organization. Fact Sheet: Colorectal Cancer.
2023.
- American Cancer Society Guideline for Colorectal Cancer
Screening. Accessed February 26, 2024. Updated November 17, 2020.
https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html
- ACS. Colorectal cancer facts and figures 2023-2025. Atlanta:
American Cancer Society; 2023.
- American Cancer Society. Can Colorectal Cancer and Polyps be
Found Early? Atlanta: American Cancer Society; 2024.
- ACS. Colorectal Cancer Rates Higher in African Americans,
Rising in Younger People. Accessed February 27, 2024. Updated
September 3, 2020.
Exact Sciences and Cologuard are registered trademarks of Exact
Sciences Corporation. Oncotype is a registered trademark of Genomic
Health, Inc., a wholly-owned subsidiary of Exact Sciences
Corporation. All third-party marks are the property of their
respective owners.
© 2024 Exact Sciences Corporation. All rights reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240307418330/en/
Media (U.S.): Lindsey Dickinson +1 608-690-0383
lidickinson@exactsciences.com
Investor Contact: Nathan Harrill +1 608-535-8659
investorrelations@exactsciences.com
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Apr 2024 to May 2024
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From May 2023 to May 2024